Targeting APOBECs in cancer: It’s about timing
Cancer Cell · 2024-04 · 42 (4) · 497-501
DOI: 10.1016/j.ccell.2024.03.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2024-04. Verfasst von Aaron N Hata und 1 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital Cancer Center, Boston, MA, USA; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Bos…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Leukemia and Lymphoma Society of Canada, Ludwig Center at Harvard.
Abstract (Originalsprache)
APOBEC3 cytidine deaminases have emerged as key drivers of mutagenesis in a wide spectrum of tumor types and are now appreciated to play a causal role in driving tumor evolution and drug resistance. As efforts to develop APOBEC3 inhibitors progress, understanding the timing and consequences of APOBEC3-mediated mutagenesis in distinct clinical contexts will be critical for guiding the development of anti-cancer therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Massachusetts General Hospital Cancer Center, Boston, MA, USA; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: ahata@mgh.harvard.edu.
- Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada. Electronic address: mani_larijani@sfu.ca.
Förderung
- NCI NIH HHS
- Leukemia and Lymphoma Society of Canada
- Ludwig Center at Harvard
- NIH
- Lotte and John Hecht Memorial Foundation
Zitieren
APA
Hata, A. N., & Larijani, M. (2024). Targeting APOBECs in cancer: It’s about timing. Cancer Cell, 42(4), 497-501. https://doi.org/10.1016/j.ccell.2024.03.010
Vancouver
Hata AN, Larijani M. Targeting APOBECs in cancer: It’s about timing. Cancer Cell. 2024;42(4):497-501. doi:10.1016/j.ccell.2024.03.010
BibTeX
@article{Hata2024,
author = {Hata, Aaron N and Larijani, Mani},
title = {Targeting APOBECs in cancer: It’s about timing},
journal = {Cancer Cell},
year = {2024},
volume = {42},
number = {4},
pages = {497--501},
doi = {10.1016/j.ccell.2024.03.010}
}
EUVIMED